Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!
View/ Open
Embargoed until: 2022-03-28
File version
Accepted Manuscript (AM)
Author(s)
Pope, Janet E
Nash, Peter
Fleischmann, Roy
Griffith University Author(s)
Year published
2021
Metadata
Show full item recordAbstract
The ideal state for a patient with rheumatoid arthritis (RA) is sustained remission. Contemporary treatment strategies such as early initiation of DMARD(s), optimal methotrexate dosing and treating to a target with validated outcomes have improved the likelihood of remission in RA. Remission, however defined, is not always achieved and even less often will patients with RA maintain sustained remission over time.The ideal state for a patient with rheumatoid arthritis (RA) is sustained remission. Contemporary treatment strategies such as early initiation of DMARD(s), optimal methotrexate dosing and treating to a target with validated outcomes have improved the likelihood of remission in RA. Remission, however defined, is not always achieved and even less often will patients with RA maintain sustained remission over time.
View less >
View less >
Journal Title
Arthritis & Rheumatology
Copyright Statement
© 2021 American College of Rheumatology. This is the peer reviewed version of the following article: Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!, Arthritis & Rheumatology, 2021, which has been published in final form at https://doi.org/10.1002/art.41746. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Note
This publication has been entered as an advanced online version in Griffith Research Online.
Subject
Clinical Sciences